ArticleJournal of diabetes and its complications2020

Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes.

Jeff Y Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.